- Home
- CMPX vs TPVG Comparison
CMPX vs TPVG Comparison
Compare CMPX & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- TPVG
- Stock Information
- Founded
- CMPX 2014
- TPVG 2013
- Country
- CMPX United States
- TPVG United States
- Employees
- CMPX N/A
- TPVG N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- TPVG Other Consumer Services
- Sector
- CMPX Health Care
- TPVG Consumer Discretionary
- Exchange
- CMPX Nasdaq
- TPVG Nasdaq
- Market Cap
- CMPX 229.5M
- TPVG 242.0M
- IPO Year
- CMPX N/A
- TPVG N/A
- Fundamental
- Price
- CMPX $1.82
- TPVG $6.23
- Analyst Decision
- CMPX Strong Buy
- TPVG Hold
- Analyst Count
- CMPX 8
- TPVG 6
- Target Price
- CMPX $13.13
- TPVG $6.55
- AVG Volume (30 Days)
- CMPX 762.7K
- TPVG 330.1K
- Earning Date
- CMPX 05-08-2025
- TPVG 05-07-2025
- Dividend Yield
- CMPX N/A
- TPVG 19.29%
- EPS Growth
- CMPX N/A
- TPVG N/A
- EPS
- CMPX N/A
- TPVG 0.93
- Revenue
- CMPX $850,000.00
- TPVG $101,389,000.00
- Revenue This Year
- CMPX $47.65
- TPVG N/A
- Revenue Next Year
- CMPX $2,622.79
- TPVG $5.01
- P/E Ratio
- CMPX N/A
- TPVG $6.72
- Revenue Growth
- CMPX N/A
- TPVG N/A
- 52 Week Low
- CMPX $0.77
- TPVG $5.53
- 52 Week High
- CMPX $4.08
- TPVG $9.70
- Technical
- Relative Strength Index (RSI)
- CMPX 46.49
- TPVG 49.15
- Support Level
- CMPX $1.79
- TPVG $5.87
- Resistance Level
- CMPX $1.95
- TPVG $6.18
- Average True Range (ATR)
- CMPX 0.14
- TPVG 0.18
- MACD
- CMPX 0.01
- TPVG 0.06
- Stochastic Oscillator
- CMPX 29.52
- TPVG 69.24
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.